Sky View Investment Advisors, LLC Cogent Biosciences, Inc. Transaction History
Sky View Investment Advisors, LLC
- $698 Million
- Q2 2025
A detailed history of Sky View Investment Advisors, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 10,000 shares of COGT stock, worth $149,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$149,600
Previous $60,000
20.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding COGT
# of Institutions
203Shares Held
117MCall Options Held
2.84MPut Options Held
828K-
Paradigm Biocapital Advisors LP New York, NY10.4MShares$155 Million3.47% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.49MShares$127 Million7.28% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$109 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$104 Million10.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.52MShares$97.6 Million0.0% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $984M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...